Emerging· Emerging topic under active research
Therapeutic application of adipose-derived stromal vascular fraction in diabetic foot
Zhao X., Guo J., Zhang F., Jin L.
Review describing diabetic foot pathogenesis, current treatments, and vascular remodelling as the proposed mechanism behind SVF effects.
Emerging· Emerging topic under active researchEvidence level of this study
Currently limited data exists for this topic; researchers are continuing to study it to understand future benefit and safety.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
- Study type
- Laboratory Study
- Journal
- Stem Cell Research & Therapy (2020)
- Country
- China
- Sample size
- —
- Follow-up
- Not applicable (review article)
- PMID
- 32928305
- DOI
- 10.1186/s13287-020-01825-1
What was studied
Possible mechanisms of SVF in diabetic foot, focusing on vascular remodelling.
Methods
- • Synthesised mechanistic literature and clinical applications.
Key findings
- • Proposes neovascularization as the principal mechanism of SVF benefit.
- • Notes conventional therapy is often insufficient in severe cases.
Limitations
- • A review article rather than new patient data.
- • Did not systematically appraise evidence quality.
What this study does not prove
- • A plausible mechanism is not the same as proven clinical benefit.
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Limited follow-up cannot indicate long-term outcomes.
Clinical interpretation
Useful for understanding mechanism, but not efficacy evidence.
Evidence level: Emerging topic under active research